Sahera Dirajlal-Fargo1,2,3, Abdus Sattar3, Jiao Yu3, Zainab Albar3, Fabio C Chaves4, Ken Riedl4, Cissy Kityo5, Emily Bowman6, Grace A McComsey1,2,3, Nicholas Funderburg6. 1. University Hospitals Cleveland Medical Center. 2. Rainbow Babies and Children's Hospital. 3. Case Western Reserve University, Cleveland. 4. Department of Food Science and Technology, and the OSU Comprehensive Cancer Center, The Ohio State University, OH, USA. 5. Joint Clinical Research Centre, Kampala, Uganda. 6. Ohio State University School of Health and Rehabilitation Sciences, Columbus, OH, USA.
Abstract
OBJECTIVE: HIV infection and antiretroviral therapy (ART) have both been linked to dyslipidemia and increased cardiovascular disease (CVD). The relationships among the lipidome, immune activation, and subclinical vascular disease in children with perinatally acquired HIV (PHIV) have not been investigated. METHODS: Serum lipid composition, including 13 lipid classes constituting 850 different lipid species were measured by direct infusion-tandem mass spectrometry in samples from 20 ART-treated PHIV and 20 age-matched and sex-matched HIV- Ugandan children. All participants were between 10 and 18 years of age with no other known active infections. PHIVs had HIV-1 RNA level 50 copies/ml or less. In addition, common carotid artery intima--media thickness (IMT), as well as plasma marker of systemic inflammation (hsCRP, IL6, sTNFRa I), monocyte activation (soluble CD14 and CD163), and T-cell activation (expression of CD38 and HLA-DR on CD4+ and CD8+) were evaluated. RESULTS: Median age (Q1, Q3) of study participants was 13 years (11, 15), 37% were boys, 75% were on an NNRTI-based ART regimen. The concentrations of cholesterol ester, LCER, phosphatidylcholines, and sphingomyelin lipid classes were significantly increased in serum of PHIV compared with HIV (P≤0.04). Biomarkers associated with CVD risk including hsCRP, sCD163, and T-cell activation were directly correlated with lipid species in PHIV (P ≤ 0.04). Contents of free fatty acids including palmitic (16 : 0), stearic (18 : 0), and arachidic acid (20 : 0) were positively correlated with IMT in PHIV. CONCLUSION: Serum lipidome is altered in young virally suppressed PHIV on ART. A direct association between inflammation and lipid species known to be associated with CVD was observed.
OBJECTIVE: HIV infection and antiretroviral therapy (ART) have both been linked to dyslipidemia and increased cardiovascular disease (CVD). The relationships among the lipidome, immune activation, and subclinical vascular disease in children with perinatally acquired HIV (PHIV) have not been investigated. METHODS: Serum lipid composition, including 13 lipid classes constituting 850 different lipid species were measured by direct infusion-tandem mass spectrometry in samples from 20 ART-treated PHIV and 20 age-matched and sex-matched HIV- Ugandan children. All participants were between 10 and 18 years of age with no other known active infections. PHIVs had HIV-1 RNA level 50 copies/ml or less. In addition, common carotid artery intima--media thickness (IMT), as well as plasma marker of systemic inflammation (hsCRP, IL6, sTNFRa I), monocyte activation (soluble CD14 and CD163), and T-cell activation (expression of CD38 and HLA-DR on CD4+ and CD8+) were evaluated. RESULTS: Median age (Q1, Q3) of study participants was 13 years (11, 15), 37% were boys, 75% were on an NNRTI-based ART regimen. The concentrations of cholesterol ester, LCER, phosphatidylcholines, and sphingomyelin lipid classes were significantly increased in serum of PHIV compared with HIV (P≤0.04). Biomarkers associated with CVD risk including hsCRP, sCD163, and T-cell activation were directly correlated with lipid species in PHIV (P ≤ 0.04). Contents of free fatty acids including palmitic (16 : 0), stearic (18 : 0), and arachidic acid (20 : 0) were positively correlated with IMT in PHIV. CONCLUSION: Serum lipidome is altered in young virally suppressed PHIV on ART. A direct association between inflammation and lipid species known to be associated with CVD was observed.
Authors: Allison Ross Eckard; Paolo Raggi; Joshua H Ruff; Mary Ann O'Riordan; Julia C Rosebush; Danielle Labbato; Julie E Daniels; Monika Uribe-Leitz; Christopher T Longenecker; Grace A McComsey Journal: Virulence Date: 2017-03-21 Impact factor: 5.882
Authors: Allison M Hodge; Dallas R English; Kerin O'Dea; Andrew J Sinclair; Maria Makrides; Robert A Gibson; Graham G Giles Journal: Am J Clin Nutr Date: 2007-07 Impact factor: 7.045
Authors: Marietta Charakida; Stavros P Loukogeorgakis; Michael I Okorie; Stefano Masi; Julian P Halcox; John E Deanfield; Nigel J Klein Journal: Antivir Ther Date: 2009
Authors: Javier Martínez-Sanz; María Visitación Calvo; Sergio Serrano-Villar; María Luisa Montes; Rosa Martín-Mateos; Diego Burgos-Santamaría; Jorge Díaz-Álvarez; Alba Talavera-Rodríguez; Marta Rosas; Santiago Moreno; Javier Fontecha; Matilde Sánchez-Conde Journal: J Clin Med Date: 2022-07-02 Impact factor: 4.964